Track Pear Therapeutics's total assets ($95M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (December 2022), PEAR shows a total assets of $95M. That compares with $200M in the prior-year period — down 51.8% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, PEAR's total assets is now $95M (was $200M) — a 51.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Pear Therapeutics is outperforming or lagging.
Tracking PEAR's total assets over time shows whether Pear Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $95M That compares with $200M in the prior-year period — down 51.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total assets page, Stockcircle has Pear Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $95M) with ownership activity and broader fundamentals.